Health news
The Food and Drug Administration (FDA) has revised the authorizations for bamlanivimab plus etesevimab and REGEN-COV (casirivimab and imdevimab) to limit the use of these monoclonal antibodies only to patients who are likely infected with…
The Food and Drug Administration (FDA) has approved Medtronic’s IntellisTM rechargeable neurostimulator and VantaTM recharge-free neurostimulator for the treatment of pain associated with diabetic peripheral neuropathy (DPN). These implantable spinal cord stimulation (SCS) devices were…
The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems for use on closed surgical incisions to aid in reducing the incidence of…
Subcision combined with hyaluronic acid (HA) or popoly-L-lactic acid (PLLA) threads may better reduce the appearance of atrophic acne scars than subcision alone, suggests study data published in the Journal of Cosmetic Dermatology. This split-face…
Patients with type 2 diabetes (T2D) had significantly greater reductions in glycated hemoglobin (HbA1c) and body weight with semaglutide vs dulaglutide, according to results published in the Journal of Clinical Endocrinology & Metabolism. Both are…
Among patients in South Africa who contracted SARS-CoV-2 infection during the wave dominated by the Omicron (B.1.1529) variant, fewer required hospitalization, supplemental oxygen, or transfer to an intensive care unit (ICU) compared with previous waves,…
At this point, there is simply no question. The COVID shots are an abysmal failure in every way possible. Again and again, data analyses from around the world show a negative correlation between “vaccination” rates…
This article was previously published February 26, 2020, and has been updated with new information. Aside from causing a wide variety of side effects in those who take medications, the widespread routine use of pharmaceuticals…
Women around the globe have reported changes in their menstrual cycles following COVID-19 shots. Changes include heavier and more painful periods1 and changes in menses length, as well as unexpected breakthrough bleeding or spotting among…
The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Merck regarding the New Drug Application for gefapixant for the treatment of adults with refractory or unexplained chronic cough. Gefapixant is…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021